In this review, we will describe the IgA function on the gut microbiome and gut–liver axis, and discuss the potential role of IgA for liver diseases, especially ALD and NAFLD/NASH. The gene discussed is CD79A; the disease is metabolic dysfunction-associated steatohepatitis.